The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer PatientsVincenzo Quagliariello, Nicola Maurea, Domenico Gabrielli et al.|Cancers|2024Cited by 14
PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 Pathway InhibitionVincenzo Quagliariello, Nicola Maurea, Massimiliano Berretta et al.|International Journal of Molecular Sciences|2025Cited by 8
Time to Combinatorial Regimens: SGLT2i and PCSK9i in High-Risk Cardio-Oncology PatientsVincenzo Quagliariello, Nicola Maurea, Massimiliano Berretta et al.|Journal of Cardiovascular Pharmacology|2025Cited by 4
Effect of anti CTLA-4 and PD-1 monoclonal antibodies on systemic SDF-1 and galectin-3 levels through NLRP3 and MyD-88 pathways in preclinical models.Martina Iovine, Nicola Maurea, Vincenzo Quagliariello et al.|Journal of Clinical Oncology|2024Cited by 3
Effect of sodium-glucose cotransporter 2 inhibitor dapagliflozin on ejection fraction reduction, myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity.Vincenzo Quagliariello, Nicola Maurea, Maria Laura Canale et al.|Journal of Clinical Oncology|2024Cited by 3